![](/img/cover-not-exists.png)
PBI15 COST PER RESPONDER ANALYSIS OF GUSELKUMAB VS SECUKINUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Saad, R., Santana, P., Fioratti, C., Rachid, M.L., Decimoni, T.C., Brunelli, M.J., Laranjeira, F.O.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.098
Date:
May, 2019
File:
PDF, 376 KB
2019